Antibody ligation of human leukocyte antigen class I molecules stimulates migration and proliferation of smooth muscle cells in a focal adhesion kinase-dependent manner

Human Immunology

Volumn 72, Issue 12, 2011, Pages 1150-1159

  Li, Fang ^a   Zhang, Xiaohai ^a   Jin, Yi Ping ^a   Mulder, Arend ^b   Reed, Elaine F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anti HLA antibodies; Cell migration; Cell proliferation; Focal adhesion kinase; Human smooth muscle cells

Indexed keywords

FOCAL ADHESION KINASE; HLA ANTIBODY; HLA ANTIGEN CLASS 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SMALL INTERFERING RNA;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CROSS LINKING; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LIGATION; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

ANTIBODIES; AORTA; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; FLOW CYTOMETRY; FOCAL ADHESION KINASE 1; GENE EXPRESSION REGULATION; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; ORGAN TRANSPLANTATION; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 81955164183     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.09.004     Document Type: Article

References (49)

1. Hosenpud J.D., Bennett L.E., Keck B.M., Fiol B., Boucek M.M., Novick R.J. The Registry of the International Society for Heart and Lung Transplantation fifteenth official report. J Heart Lung Transplant 1998, 1998:656-668.
2. Kamoun M. Mechanisms of chronic allograft dysfunction. Ther Drug Monit 2006, 28:14-18.
3. Billingham M.E. Pathology of graft vascular disease after heart and heart-lung transplantation and its relationship to obliterative bronchiolitis. Transplant Proc 1995, 27:2013-2016.
4. Kennedy L.J., Weissman I.L. Dual origin of intimal cells in cardiac-allograft arteriosclerosis. N Engl J Med 1971, 285:884-887.
5. Weis M., von Scheidt W. Cardiac allograft vasculopathy: A review. Circulation 1997, 96:2069-2077.
6. Jeannet M., Pinn V.W., Flax M.H., Winn H.J., Russell P.S. Humoral antibodies in renal allotransplantation in man. N Engl J Med 1970, 282:111-117.
7. Vasilescu E.R., Ho E.K., de la TORre L., Itescu S., Marboe C., Cortesini R., et al. Anti-HLA antibodies in heart transplantation. Transpl Immunol 2004, 12:177-183.
8. O'Connell T.X., Mowbray J.F. Arterial intimal thickening produced by alloantibody and xenoantibody. Transplantation 1973, 15:262-263.
9. Michaels P.J., Espejo M.L., Kobashigawa J., Alejos J.C., Burch C., Takemoto S., et al. Humoral rejection in cardiac transplantation: Risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 2003, 22:58-69.
10. Arosa F.A., Santos S.G., Powis S.J. Open conformers: The hidden face of MHC-I molecules. Trends Immunol 2007, 28:115-123.
11. Jin Y.P., Fishbein M.C., Said J.W., Jindra P.T., Rajalingam R., Rozengurt E., et al. Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells. Hum Immunol 2004, 65:291-302.
12. Jindra P.T., Jin Y.P., Jacamo R., Rozengurt E., Reed E.F. MHC class I and integrin ligation induce ERK activation via an mTORC2-dependent pathway. Biochem Biophys Res Commun 2008, 369:781-787.
13. Jindra P.T., Jin Y.P., Rozengurt E., Reed E.F. HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway. J Immunol 2008, 180:2357-2366.
14. Narayanan K., Jendrisak M.D., Phelan D.L., Mohanakumar T. HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway. Transpl Immunol 2006, 15:187-197.
15. Jin Y.P., Korin Y., Zhang X., Jindra P.T., Rozengurt E., Reed E.F. RNA interference elucidates the role of focal adhesion kinase in HLA class I-mediated focal adhesion complex formation and proliferation in human endothelial cells. J Immunol 2007, 178:7911-7922.
16. Lepin E.J., Zhang Q., Zhang X., Jindra P.T., Hong L.S., Ayele P., et al. Phosphorylated S6 ribosomal protein: A novel biomarker of antibody-mediated rejection in heart allografts. Am J Transplant 2006, 6:1560-1571.
17. Jindra P.T., Hsueh A., Hong L., Gjertson D., Shen X.D., Gao F., et al. Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts. J Immunol 2008, 180:2214-2224.
18. Zhang X., Rozengurt E., Reed E.F. HLA class I molecules partner with integrin beta4 to stimulate endothelial cell proliferation and migration. Sci Signal 2010, 3:ra85.
19. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498.
20. Wallace P.K., Muirhead K.A. Cell tracking 2007: A proliferation of probes and applications. Immunol Investig 2007, 36:527-561.
21. Bell L., Madri J.A. Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells. Circ Res 1989, 65:1057-1065.
22. Parsons J.T. Focal adhesion kinase: The first ten years. J Cell Sci 2003, 116:1409-1416.
23. Hildebrand J.D., Schaller M.D., Parsons J.T. Identification of sequences required for the efficient localization of the focal adhesion kinase, pp125FAK, to cellular focal adhesions. J Cell Biol 1993, 123:993-1005.
24. Yokouchi K., Numaguchi Y., Kubota R., Ishii M., Imai H., Murakami R., et al. l-caldesmon regulates proliferation and migration of vascular smooth muscle cells and inhibits neointimal formation after angioplasty. Arterioscler Thromb Vasc Biol 2006, 26:2231-2237.
25. Gahtan V., Wang X.J., Ikeda M., Willis A.I., Tuszynski G.P., Sumpio B.E. Thrombospondin-1 induces activation of focal adhesion kinase in vascular smooth muscle cells. J Vasc Surg 1999, 29:1031-1036.
26. Hauck C.R., Hsia D.A., Schlaepfer D.D. Focal adhesion kinase facilitates platelet-derived growth factor-BB-stimulated ERK2 activation required for chemotaxis migration of vascular smooth muscle cells. J Biol Chem 2000, 275:41092-41099.
27. Galvani S., Augé N., Calise D., Thiers J.C., Canivet C., Kamar N., et al. HLA class I antibodies provoke graft arteriosclerosis in human arteries transplanted into SCID/beige mice. Am J Transplant 2009, 9:2607-2614.
28. Uehara S., Chase C.M., Cornell L.D., Madsen J.C., Russell P.S., Colvin R.B. Chronic cardiac transplant arteriopathy in mice: Relationship of alloantibody, C4d deposition and neointimal fibrosis. Am J Transplant 2007, 7:57-65.
29. Wu G.D., Jin Y.S., Salazar R., Dai W.D., Barteneva N., Barr M.L., et al. Vascular endothelial cell apoptosis induced by anti-donor non-MHC antibodies: A possible injury pathway contributing to chronic allograft rejection. J Heart Lung Transplant 2002, 21:1174-1187.
30. Hirohashi T., Uehara S., Chase C.M., DellaPelle P., Madsen J.C., Russell P.S., et al. Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice. Am J Transplant 2010, 10:510-517.
31. Russell P.S., Chase C.M., Colvin R.B. Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: Lack of progression to sclerotic lesions in B cell-deficient mice. Transplantation 1997, 64:1531-1536.
32. Hara K., Maruki Y., Long X., Yoshino K., Oshiro N., Hidayat S., et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 2002, 110:177-189.
33. Kim D.H., Sarbassov D.D., Ali S.M., King J.E., Latek R.R., Erdjument-Bromage H., et al. MTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002, 110:163-175.
34. Nojima H., Tokunaga C., Eguchi S., Oshiro N., Hidayat S., Yoshino K., et al. The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif. J Biol Chem 2003, 278:15461-15464.
35. Jacinto E., Loewith R., Schmidt A., Lin S., Rüegg M.A., Hall A., et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 2004, 6:1122-1128.
36. Sarbassov D.D., Guertin D.A., Ali S.M., Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005, 307:1098-1101.
37. Oudit G.Y., Sun H., Kerfant B.G., Crackower M.A., Penninger J.M., Backx P.H. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol 2004, 37:449-471.
38. Martin K.A., Rzucidlo E.M., Merenick B.L., Fingar D.C., Brown D.J., Wagner R.J., et al. The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation. Am J Physiol Cell Physiol 2004, 286:C507-C517.
39. Martin K.A., Merenick B.L., Ding M., Fetalvero K.M., Rzucidlo E.M., Kozul C.D., et al. Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling. J Biol Chem 2007, 282:36112-36120.
40. Clausell N., Molossi S., Rabinovitch M. Increased interleukin-1beta and fibronectin expression are early features of the development of the postcardiac transplant coronary arteriopathy in piglets. Am J Pathol 1993, 142:1772-1786.
41. Streblow D.N., Kreklywich C.N., Smith P., Soule J.L., Meyer C., Yin M., et al. Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33. Am J Transplant 2005, 5:436-442.
42. Li G., Jin R., Norris R.A., Zhang L., Yu S., Wu F., et al. Periostin mediates vascular smooth muscle cell migration through the integrins alphavbeta3 and alphavbeta5 and focal adhesion kinase (FAK) pathway. Atherosclerosis 2010, 208:358-365.
43. Eliceiri B.P., Puente X.S., Hood J.D., Stupack D.G., Schlaepfer D.D., Huang X.Z., et al. Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling. J Cell Biol 2002, 157:149-160.
44. Slack J.K., Adams R.B., Rovin J.D., Bissonette E.A., Stoker C.E., Parsons J.T. Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells. Oncogene 2001, 20:1152-1163.
45. Taylor J.M., Mack C.P., Nolan K., Regan C.P., Owens G.K., Parsons J.T. Selective expression of an endogenous inhibitor of FAK regulates proliferation and migration of vascular smooth muscle cells. Mol Cell Biol 2001, 21:1565-1572.
46. Koshman Y.E., Engman S.J., Kim T., Iyengar R., Henderson K.K., Samarel A.M. Role of FRNK tyrosine phosphorylation in vascular smooth muscle spreading and migration. Cardiovasc Res 2010, 85:571-581.
47. Brewster L.P., Ucuzian A.A., Brey E.M., Liwanag M., Samarel A.M., Greisler H.P. FRNK overexpression limits the depth and frequency of vascular smooth muscle cell invasion in a three-dimensional fibrin matrix. J Cell Physiol 2010, 225:562-568.
48. Koshman Y.E., Kim T., Chu M., Engman S.J., Iyengar R., Robia S.L., et al. FRNK inhibition of focal adhesion kinase-dependent signaling and migration in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2010, 30:2226-2233.
49. Bieri M., Oroszlan M., Farkas A., Ligeti N., Bieri J., Mohacsi P. Anti-HLA I antibodies induce VEGF production by endothelial cells, which increases proliferation and paracellular permeability. Int J Biochem Cell Biol 2009, 41:2422-2430.